Leticia Szadai | Medicine and Dentistry | Best Researcher Award

Published on by Invention Awards

Best Researcher Award

Leticia Szadai
Lund University, Sweden

Leticia Szadai
Affiliation Lund University
Country Sweden
Google Scholar ID CNcrXOIAAAAJ
Documents 27
Citations 175
h-index 7
Subject Area Medicine and Dentistry
Event International Invention Awards

The Best Researcher Award recognizes researchers whose scholarly activities have contributed to the advancement of knowledge and innovation within their respective disciplines. Leticia Szadai of Lund University has developed a research profile centered on melanoma biology, proteomics, biomarker discovery, and translational cancer research. Her work integrates advanced molecular analysis with clinical applications, supporting improved understanding of melanoma progression, recurrence mechanisms, and therapeutic opportunities. Through collaborative research efforts, she has contributed to the generation of valuable datasets and analytical frameworks relevant to modern oncology research.[1]

Abstract

This article summarizes the academic achievements and research contributions of Leticia Szadai. Her work primarily focuses on melanoma proteomics, molecular pathology, biomarker identification, and translational oncology. Through participation in multidisciplinary investigations, she has contributed to the development of proteomic resources and analytical methods that support precision medicine approaches in cancer research.[2]

Keywords

Melanoma, Proteomics, Molecular Pathology, Biomarkers, Translational Medicine, Cancer Research, Precision Oncology, Tumor Biology.

Introduction

Advances in cancer research increasingly depend on interdisciplinary methodologies that connect molecular science with clinical practice. Leticia Szadai has contributed to this field through studies examining melanoma biology and the molecular factors associated with disease progression and recurrence. Her research reflects contemporary efforts to improve diagnostic and prognostic strategies through large-scale proteomic investigation.[3]

Research Profile

As a researcher affiliated with Lund University, Leticia Szadai has participated in projects involving molecular oncology, clinical proteomics, and translational medicine. Her publication record demonstrates engagement with collaborative international research initiatives focused on melanoma tissue analysis, mitochondrial regulation, immune response mechanisms, and biomarker discovery. These efforts contribute to the broader objective of enhancing evidence-based cancer management.[4]

Research Contributions

  • Contributed to studies establishing comprehensive melanoma proteome atlases.
  • Investigated molecular pathology and protein expression patterns in melanoma.
  • Explored mitochondrial dysfunction and immune response dysregulation associated with melanoma recurrence.
  • Participated in biomarker discovery using archived tumor samples and advanced proteomic technologies.
  • Supported research into kinase signaling pathways and translational applications in oncology.

Publications

  • The Human Melanoma Proteome Atlas—Complementing the Melanoma Transcriptome (2021).
  • The Human Melanoma Proteome Atlas—Defining the Molecular Pathology (2021).
  • Mitochondrial and Immune Response Dysregulation in Melanoma Recurrence (2023).
  • Deep Proteomic Analysis on Biobanked Paraffin-Archived Melanoma with Prognostic/Predictive Biomarker Read-Out (2021).
  • A Biobanking Turning-Point in the Use of Formalin-Fixed, Paraffin Tumor Blocks to Unveil Kinase Signaling in Melanoma (2021).

Research Impact

The available citation metrics indicate that Leticia Szadai’s research outputs have attracted scholarly attention within oncology and translational medicine communities. Her involvement in high-impact collaborative studies has supported the development of proteomic resources that facilitate future investigations into melanoma progression, biomarker validation, and personalized therapeutic strategies. These contributions demonstrate measurable academic influence and continuing relevance to cancer research.[5]

Award Suitability

Leticia Szadai’s research portfolio aligns with the objectives of the International Invention Awards and the Best Researcher Award category. Her scholarly contributions reflect innovation in proteomic methodology, translational cancer research, and biomarker development. The combination of publication activity, collaborative leadership, and clinically relevant outcomes supports recognition for contributions to medicine and dentistry-related scientific advancement.[6]

Conclusion

Leticia Szadai has established a research profile characterized by rigorous investigation of melanoma biology and proteomics. Her contributions to translational oncology, biomarker discovery, and molecular pathology have supported scientific understanding of cancer mechanisms and potential clinical applications. These achievements provide a strong foundation for academic recognition through the Best Researcher Award.

References

  1. Elsevier. (n.d.). Google Scholar author details: Leticia Szadai
    https://scholar.google.com/citations?hl=hu&user=CNcrXOIAAAAJ
  2. Betancourt LH et al. (2021). The Human Melanoma Proteome Atlas—Complementing the Melanoma Transcriptome. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.451
  3. Betancourt LH et al. (2021). The Human Melanoma Proteome Atlas—Defining the Molecular Pathology. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.473
  4. Szadai L et al. (2023). Mitochondrial and Immune Response Dysregulation in Melanoma Recurrence. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.1495
  5. Szadai L et al. (2021). Deep Proteomic Analysis on Biobanked Paraffin-Archived Melanoma with Prognostic/Predictive Biomarker Read-Out. Cancers.
    https://doi.org/10.3390/cancers13236105
  6. Velasquez E et al. (2021). A Biobanking Turning-Point in the Use of Formalin-Fixed, Paraffin Tumor Blocks to Unveil Kinase Signaling in Melanoma. Clinical and Translational Medicine.
    https://doi.org/10.1002/ctm2.466

A. Marcell Szasz | Medicine and Dentistry | Excellence in Research Award

Published on by Invention Awards

Excellence in Research Award

A. Marcell Szasz
Semmelweis University, Hungary

A. Marcell Szasz
Affiliation Semmelweis University
Country Hungary
Scopus ID 24723204500
Documents 147
Citations 4,107
h-index 29
Subject Area Medicine and Dentistry
Event International Invention Awards
Google Scholar ID eeJzLNQAAAAJ

The Excellence in Research Award recognizes researchers whose scholarly activities demonstrate sustained contributions to scientific advancement, interdisciplinary collaboration, and measurable research impact. A. Marcell Szasz of Semmelweis University has developed a notable academic profile in medicine and cancer research through influential publications, biomarker studies, translational oncology investigations, and evidence-based clinical analyses.[1] His publication record and citation performance indicate significant engagement within the international scientific community.[2]

Abstract

A. Marcell Szasz has contributed to the fields of oncology, molecular medicine, prognostic biomarker analysis, and cancer outcome prediction. His research portfolio encompasses gene-expression studies, clinical meta-analyses, cancer progression modeling, and translational medical investigations. Through collaborations with international research teams, his work has informed understanding of disease mechanisms and patient stratification approaches in modern oncology.[2]

Keywords

Oncology, Biomarkers, Precision Medicine, Cancer Research, Meta-analysis, Gene Expression, Translational Medicine, Clinical Research.

Introduction

Research excellence is frequently evaluated through scientific influence, publication quality, citation impact, and contribution to knowledge development. Within this context, A. Marcell Szasz has established a scholarly presence through studies addressing cancer biology, prognostic biomarkers, and therapeutic outcomes. His work contributes to evidence-based approaches used in clinical and translational medicine.[3]

Research Profile

The researcher maintains a substantial publication portfolio consisting of 147 indexed documents, more than 4,100 citations, and an h-index of 29. His academic activity is primarily associated with medicine, oncology, pathology, molecular diagnostics, and clinical outcome assessment. These metrics reflect both productivity and sustained visibility within international scientific literature.[1]

Research Contributions

  • Investigation of microRNA regulation and metastatic progression in breast cancer.
  • Development and validation of transcriptomic biomarkers associated with survival outcomes.
  • Comprehensive meta-analyses supporting clinical decision-making in oncology.
  • Studies examining genomic alterations and evolutionary pathways of metastatic disease.

Publications

Among his most cited publications are studies on miR-31 and breast cancer metastasis, transcriptomic biomarker validation in gastric cancer, urachal carcinoma meta-analysis, tamoxifen-response biomarkers, and phylogenetic analyses of metastatic progression.[4] These works have received substantial scholarly attention and have been referenced extensively in subsequent research.

Research Impact

The citation performance associated with A. Marcell Szasz demonstrates broad engagement from researchers across oncology, pathology, molecular biology, and clinical medicine. His publications have contributed to methodological refinement, biomarker validation, and evidence synthesis efforts that support future investigations and clinical translation.[5]

Award Suitability

The Excellence in Research Award emphasizes scientific rigor, research influence, and sustained scholarly contribution. Based on publication metrics, citation impact, interdisciplinary collaborations, and documented contributions to cancer research, A. Marcell Szasz demonstrates characteristics commonly associated with distinguished academic achievement and research leadership.[6]

Conclusion

A. Marcell Szasz has contributed meaningfully to contemporary oncology research through studies addressing biomarkers, disease progression, and clinical outcomes. His publication record, citation profile, and participation in influential collaborative projects provide a strong foundation for recognition within an academic award framework focused on research excellence.

References

  1. Elsevier. (n.d.). Scopus author details: A. Marcell Szasz, Author ID 24723204500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=24723204500
  2. Valastyan S., Reinhardt F., et al. (2009). miR-31 inhibits breast cancer metastasis. Cell.
    DOI: https://doi.org/10.1016/j.cell.2009.03.047
  3. Szász A.M., Lánczky A., et al. (2016). Cross-validation of survival associated biomarkers in gastric cancer. Oncotarget.
    DOI: https://doi.org/10.18632/oncotarget.10337
  4. Brown D., Smeets D., Székely B., Szasz A.M., et al. (2017). Phylogenetic analysis of metastatic progression in breast cancer. Nature Communications.
    DOI: https://doi.org/10.1038/ncomms14944
  5. Mihály Z., Kormos M., Lánczky A., et al. (2013). Gene expression-based biomarkers predicting outcome after tamoxifen treatment.
    DOI: https://doi.org/10.1007/s10549-013-2619-y
  6. Szarvas T., Módos O., Niedworok C., et al. (2016). Clinical, prognostic, and therapeutic aspects of urachal carcinoma.
    DOI: https://doi.org/10.1016/j.urolonc.2016.04.012

Ana Maria Mihai | Medicine and Dentistry | Excellence in Research Award

Published on by Invention Awards
After Completing the Registration Process, your Biography will be displayed here.

Register by using your Entry ID: 26242

Register Here

 

Gaia Cattador | Medicine and Dentistry | Research Excellence Award

Published on by Invention Awards

Dr. Gaia Cattador | Medicine and Dentistry | Research Excellence Award

Cardiologist in Multimedical, Italy

Dr. Gaia Cattadori is a highly accomplished cardiologist with an extensive academic, clinical, and research career in cardiovascular medicine. She earned her medical degree with top honors and completed her specialization in cardiology, followed by national academic qualification as an associate professor in cardiovascular and respiratory diseases. She has held long-standing teaching roles in medical and healthcare programs, mentoring students and contributing to professional training across multiple academic levels. Her clinical career includes leadership positions in cardiac rehabilitation and heart failure units, with deep expertise in cardiopulmonary exercise testing and cardiovascular physiology. She has been actively involved in numerous national and international research projects, often serving as principal or co-investigator, focusing on heart failure, rehabilitation, and cardiopulmonary function. She has coordinated and participated in multidisciplinary and multicenter research networks, contributing to advancements in clinical cardiology. Her work also includes organizing and leading research groups and registries, particularly in heart failure and elderly patient care. She has been a frequent speaker and organizer at major scientific conferences, presenting on topics such as cardiac rehabilitation, heart failure management, and exercise physiology. Her contributions extend to collaborative international studies and clinical trials aimed at improving patient outcomes. In recognition of her academic excellence and research contributions, she has received prestigious awards for young researchers and professional merit.

Citation Metrics (Scopus)

4000
3500
3000
2500
2000
1500
1000
500
100
0

Citations
3582

Documents
109

h-index
36

Citations

Documents

h-index

View Scopus Profile

Featured Publications

 

Shuying Shen | Health Professions | Excellence in Innovation Award

Published on by Invention Awards

Prof. Shuying Shen | Health Professions | Excellence in Innovation Award 

 Zhejiang University | China

Dr. Shuying Shen is a distinguished research fellow at Sir Run Run Shaw Hospital affiliated with the Medical College of Zhejiang University, where she has established a strong research presence in musculoskeletal biology, molecular regulation, and osteoarthritis pathology. She earned her Ph.D. in Biochemistry and Molecular Biology in 2017 and her Bachelor’s degree in Applied Bioscience in 2012, both from Zhejiang University. Dr. Shen’s research has been continuously supported by major competitive grants, including the National Natural Science Foundation of China Excellent Young Scholars Fund, multiple NSFC General Programs, and the Zhejiang Provincial Outstanding Youth Project. Her funded projects focus on elucidating mechanisms of protein post-translational modification, chondrocyte aging, metabolic reprogramming in osteosarcoma, and non-classical regulatory pathways in chondrocyte physiology, reflecting her deep engagement with both degenerative diseases and cancer biology. Dr. Shen has made influential contributions to the understanding of noncoding RNA functions in osteoarthritis progression, osteosarcoma development and metastasis, and organ size regulation. Her work reveals how circular RNAs, microRNAs, and RNA–protein interactions shape cellular senescence, lipid metabolism, autophagy, and energy homeostasis. She has also advanced knowledge on the interplay between metabolic remodeling and epigenetic regulation in cartilage degeneration. Her publications demonstrate innovative approaches combining molecular biology, functional genomics, epigenetics, and translational models to uncover therapeutic targets for osteoarthritis, intervertebral disc degeneration, and malignancies. Dr. Shen has published 87 peer-reviewed papers, including 50 as first or corresponding author, in top-tier journals such as Nature Aging, Science Translational Medicine, Cell Research, Nature Communications, Annals of the Rheumatic Diseases, PNAS, Advanced Science, Molecular Cancer, Bone Research, and Molecular Therapy. Her research has been cited more than 3,000 times, and she holds an H-index of 37, underscoring her strong scientific influence. Through her pioneering discoveries—such as the regulation of chondrocyte senescence by palmitoylation, the role of fatty acid oxidation in osteoarthritis, circRNA-mediated metabolic control, and noncoding RNA networks in osteosarcoma—Dr. Shen has significantly advanced the field of musculoskeletal molecular medicine. Her long-term research goal is to develop novel diagnostic markers and targeted therapies for osteoarthritis and related degenerative diseases through a deeper understanding of RNA regulation, protein modifications, and metabolic homeostasis.

Profile: Scopus

Featured Publications

Wang, K., He, W., Gong, Z., Gao, J., Gao, T., Pan, N., Wu, D., Yang, Y., Li, Z., Zhao, X., Ji, M., & Shen, S. Y. (2025). ZDHHC11-mediated palmitoylation alleviates chondrocyte senescence and serves as a therapeutic target for osteoarthritis. Nature Aging.

Mei, Z., Yilamu, K., Ni, W., Shen, P., Pan, N., Chen, H., Su, Y., Guo, L., Sun, Q., Li, Z., Huang, D., Fang, X., Fan, S., Zhang, H., & Shen, S. Y. (2025). Chondrocyte fatty acid oxidation drives osteoarthritis via SOX9 degradation and epigenetic regulation. Nature Communications, 16(1), 4892.

Gong, Z., Zhu, J., Chen, J., Feng, F., Zhang, H., Zhang, Z., Song, C., Liang, K., Yang, S., Fan, S., Fang, X., & Shen, S. Y. (2023). CircRREB1 mediates lipid metabolism–related senescent phenotypes in chondrocytes through FASN post-translational modifications. Nature Communications, 14(1), 5242.

Li, Z., Zhang, W., Wei, X. Y., Hu, J. Z., Hu, X., Liu, H., Lu, J., Shen, S. Y., & Ji, M. L. (2025). TRIM15 drives chondrocyte senescence and osteoarthritis progression. Science Translational Medicine, 17(791), eadq1735.

Shen, S. Y., Guo, X. C., Yan, H., Lu, Y., Ji, X. Y., Li, L., Liang, T. B., Zhou, D. W., Zhao, J. C., Yu, J. D., Gong, X. G., Zhang, L., & Zhao, B. (2015). A miR-130a–YAP positive feedback loop promotes organ size and tumorigenesis. Cell Research, 25(9), 997–1012.

Shen, S. Y., Wu, Y. Z., Chen, J. X., Xie, Z., Huang, K. M., Wang, G. L., Yang, Y. T., Ni, W. Y., Chen, Z. J., Shi, P. H., Ma, Y., & Fan, S. W. (2019). CircSERPINE2 protects against osteoarthritis by targeting miR-1271 and ETS-related gene. Annals of the Rheumatic Diseases, 78(6), 826–836.

Shen, S. Y., Yang, Y. T., Shen, P. Y., Ma, J., Fang, B., Wang, Q. X., Wang, K. F., Shi, P. H., Fan, S. W., & Fang, X. Q. (2021). circPDE4B prevents articular cartilage degeneration and promotes repair by acting as a scaffold for RIC8A and MID1. Annals of the Rheumatic Diseases, 80(9), 1209–1219.

Shen, S. Y., Liang, Y., Zhao, Y., Hu, Z., Huang, Y., Wu, Y., Liu, Y., Fan, S., Wang, Q., & Xiao, P. (2024). Dietary supplementation of vitamin B1 prevents the pathogenesis of osteoarthritis. Proceedings of the National Academy of Sciences, 121(30), e2408160121.

Irineu Loturco | Health Professions | Best Researcher Award

Published on by Invention Awards

Prof Dr. Irineu Loturco | Health Professions | Best Researcher Award

Prof. Dr. Irineu Loturco | Federal University of Sao Paulo | Brazil 

Prof. Dr. Irineu Loturco Filho (born May 22, 1972, Brazil) is a distinguished researcher, educator, and practitioner in sports science, specializing in high-performance training, neuromuscular adaptations, strength, power, and speed development. He holds a degree in Sports from the University of São Paulo (1999), a Professional Master’s in High-Performance Sports from Universidad Autónoma de Madrid (2009), and both a Master’s (2010) and PhD (2014) in High-Performance Sports from Universidad Pablo de Olavide, Spain, where his research focused on the effects of training load sequencing on strength, speed, and muscle power. Loturco currently serves as Director of Sport Science & Research Leader at the Núcleo de Alto Rendimento Esportivo de São Paulo (NAR-SP), coordinating postgraduate programs in training methodology and supervising research on training periodization, performance monitoring, and neuromuscular development. He is also a professor and advisor at the Federal University of São Paulo (UNIFESP) and a visiting professor at the University of South Wales, contributing to both national and international sports science research. Over his career, he has worked with elite athletes and professional teams including Clube Atlético Mineiro, Sociedade Esportiva Palmeiras, and Sport Club Corinthians Paulista, as well as national organizations such as the Brazilian Football Confederation and Brazilian Karate Confederation. His current research investigates strategies to enhance athletic performance, including weighted vest training, seasonal performance variation, and injury prevention. Recognized internationally for his contributions, Loturco has received awards such as the 2019 SCS Investigator Award and honors for his work in adaptive sports and high-performance athlete development, solidifying his position as a leading authority in strength and conditioning science.

Profile: Orcid

Featured Publications

Survey Studies: Connecting Sport Science to Coaching Practice – International Journal of Sports Physiology and Performance

Training at Different Velocity Zones: Does It Really Matter? – International Journal of Sports Physiology and Performance

Neuromuscular and Performance Responses to Resisted Sprint Loads in Elite Female Sprinters

Effects of a Short-Term Ballistic Training Program on Performance and Strength Deficit in Elite Youth Female Soccer Players – Sports,

Effects of Loaded and Unloaded Jumps Used as Priming Activities in Elite Male Rugby Union Players

Nicola Cosentino | Medicine and Dentistry | Breakthrough Research Award

Published on by Invention Awards

Dr. Nicola Cosentino | Medicine and Dentistry | Breakthrough Research Award

Dr. Nicola Cosentino | Centro Cardiologioco Monzino | Italy

Dr. Nicola Cosentino is a distinguished Italian cardiologist and researcher whose clinical and scientific contributions have significantly advanced the field of cardiovascular medicine. His career reflects a seamless integration of clinical excellence, research innovation, and academic leadership. With extensive expertise in acute coronary syndromes, perioperative cardiology, and intensive cardiac care, Dr. Cosentino has demonstrated a lifelong commitment to improving patient care through evidence-based medicine and cutting-edge research. His dedication is further underscored by his leadership roles within leading medical institutions and international collaborations, which have allowed him to shape both clinical practice and future research directions. Through a holistic approach that combines patient care, translational science, and teaching, Dr. Cosentino stands as a leading figure in cardiology whose work continues to impact patients, students, and the global medical community. His professional journey represents excellence, perseverance, and innovation in cardiovascular healthcare.

Profiles

Scopus
Orcid

Education

Dr. Nicola Cosentino reflects a trajectory of distinction and excellence in the medical sciences. His educational journey began with a diploma from the Classical High School in Italy, where he graduated with the highest honors, demonstrating early intellectual rigor and dedication. He subsequently earned his medical degree from the Sacred Heart Catholic University of Rome, graduating with full honors and recognition for his thesis on eosinophils in coronary atherosclerosis, conducted under the mentorship of world-renowned cardiology experts. He further specialized in cardiology with distinction at the same institution, completing his specialization with highest marks for a thesis on monocyte-derived macrophages in ischemic heart disease. To deepen his scientific expertise, Dr. Cosentino pursued a PhD in Translational Medicine at the University of Milan, consolidating his commitment to bridging laboratory science with clinical practice. His comprehensive educational training represents a balanced blend of clinical mastery and research excellence.

Experience

Dr. Nicola Cosentino has established an outstanding career marked by diverse clinical and leadership roles within some of Italy’s most prestigious medical institutions. His early professional development was shaped at the Centro Cardiologico Monzino, Milan, where he developed a strong clinical foundation in managing acute and chronic ischemic heart diseases, as well as high-risk cardiovascular conditions. Over the years, he has progressed through key roles, including staff cardiologist, head of the Acute Coronary Syndrome Unit, and medical lead manager of the Italian cardiovascular team at AstraZeneca. Most recently, he was appointed head of the Peri-Operative Cardiology Unit at Centro Cardiologico Monzino, where he now leads advanced clinical programs integrating perioperative assessment, risk management, and innovative therapeutic strategies. His professional journey combines patient care, organizational leadership, and scientific guidance, demonstrating a career that consistently bridges cutting-edge cardiology with practical, patient-centered applications in both hospital and industry settings.

Research Interest

Dr. Cosentino are centered on understanding and addressing the mechanisms underlying coronary artery disease and heart failure, both in acute and chronic presentations. His work has focused extensively on identifying novel biomarkers and molecular pathways that influence the diagnosis, prognosis, and management of these conditions. Special emphasis has been placed on investigating the role of diabetes mellitus, renal impairment, and multi-organ involvement in cardiovascular disease progression. His research also explores the clinical significance of myocardial remodeling and inflammation in acute coronary syndromes, as well as the role of advanced cardiovascular monitoring technologies. By integrating molecular science with patient-focused clinical research, Dr. Cosentino continues to contribute valuable insights into translational cardiology. His long-standing dedication has positioned him as a leading voice in precision medicine approaches, aiming to personalize treatment strategies and improve outcomes for patients facing life-threatening cardiovascular events.

Awards & Recognitions

Dr. Cosentino’s research achievements is reflected in his numerous awards and competitive research grants. His early career excellence was acknowledged through support from the Fondazione Umberto Veronesi, funding projects that examined monocyte-derived macrophages and coronary plaque morphology in ischemic heart disease. He was further awarded competitive grants from the Italian Ministry of Health, including the prestigious “Giovani Ricercatori” program for his PROMISE study on myocardial infarction and non-obstructive coronary arteries, and later through a national PNRR project exploring mitochondrial targets for stroke treatment. These recognitions highlight the innovative and impactful nature of his work, aligning with global efforts to improve cardiovascular diagnostics and therapy. Beyond financial grants, he has been entrusted with leadership positions in scientific societies and advisory committees, reflecting confidence in his scientific judgment. Collectively, these awards affirm his role as a rising leader whose contributions hold significant promise for the future of cardiovascular medicine.

Publication Top Notes

Prognostic Impact of Percutaneous Coronary Intervention in Older Patients Hospitalized with Acute Myocardial Infarction: Real-World Findings from the Lombardy Health Database

Journal: Journal of Clinical Medicine 
Authors: Giancarlo Marenzi, Nicola Cosentino, Marta Resta, Claudia Lucci, Alice Bonomi, Filippo Trombara, Michele Della Rocca, Paolo Poggio, Olivia Leoni, Francesco Bortolan et al.

Impact of Prior Statin Therapy on In-Hospital Outcome of STEMI Patients Treated with Primary Percutaneous Coronary Intervention

Journal: Journal of Clinical Medicine 
Authors: Oreste Lanza, Nicola Cosentino, Claudia Lucci, Marta Resta, Mara Rubino, Valentina Milazzo, Monica De Metrio, Filippo Trombara, Jeness Campodonico, José Pablo Werba et al.

Mitochondrial Biomarkers in Patients with ST-Elevation Myocardial Infarction and Their Potential Prognostic Implications: A Prospective Observational Study

Journal: Journal of Clinical Medicine
Authors: Nicola Cosentino; Jeness Campodonico, Marco Moltrasio, Claudia Lucci, Valentina Milazzo, Mara Rubino, Monica De Metrio, Ivana Marana; Marco Grazi, Alice Bonomi et al.

Acute Kidney Injury in Diabetic Patients With Acute Myocardial Infarction: Role of Acute and Chronic Glycemia

Journal: Journal of the American Heart Association 
Authors: Giancarlo Marenzi, Nicola Cosentino, Valentina Milazzo, Monica De Metrio, Mara Rubino, Jeness Campodonico, Marco Moltrasio, Ivana Marana, Marco Grazi, Gianfranco Lauri et al.

Association Between Haptoglobin Phenotype and Microvascular Obstruction in Patients With ST-Segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Study

Journal: JACC: Cardiovascular Imaging 
Authors: Gianluca Pontone, Daniele Andreini, Andrea I. Guaricci, Marco Guglielmo, Andrea Baggiano, Giuseppe Muscogiuri, Laura Fusini, Fabio Fazzari, Claudio Berzovini, Annalisa Pasquini et al.

Conclusion

Dr. Nicola Cosentino represents an exemplary candidate for recognition in the field of cardiology. His career is distinguished by a rare combination of clinical mastery, academic excellence, and innovative research. From his early achievements as a top graduate to his leadership roles in hospital cardiology units and industry, he has consistently demonstrated a vision to improve cardiovascular care through science and compassion. His research outputs have shaped understanding of acute coronary syndromes, myocardial remodeling, and multi-organ interactions, with direct implications for clinical practice and patient outcomes. Furthermore, his dedication to education, mentorship, and collaboration within international networks highlights his commitment to shaping the future of cardiovascular medicine. Through his pioneering research, impactful publications, and leadership contributions, Dr. Cosentino embodies the qualities of a transformative clinician-scientist. He stands as an ideal nominee for prestigious recognition, with a career that continues to inspire innovation and excellence in cardiovascular healthcare.

Mrs. Mihaela Corina Radu | Reproductive Health | Excellence in Research 

Published on by Invention Awards

Mrs. Mihaela Corina Radu | Reproductive Health | Excellence in Research 

Carol Davila University of Medicine and Pharmacy Bucharest, Romania.

Radu Mihaela Corina is a Romanian midwifery expert and academic dedicated to improving maternal healthcare. She currently serves as an Associate University Assistant at UMF Carol Davila Bucharest, contributing to both the Department of General and Specific Nursing and the Department of Microbiology, Parasitology, and Virology. With extensive clinical experience, she is also the Head Midwife at Dr. Constantin Andreoiu County Emergency Hospital. Beyond academia, she is actively engaged in European midwifery policy, serving as a member of the Ethics Committee of the European Midwives Association and as a National Expert for Romania in an EU-funded midwifery sectoral project.

Profile

Orcid

🎓 Education

Radu Mihaela Corina has pursued an extensive academic journey in the field of medicine and midwifery. She is currently a PhD candidate in Medicine (2021 – Present) at Carol Davila University of Medicine and Pharmacy, Romania, where she is advancing her expertise in maternal and reproductive healthcare. She holds a Master’s Degree in Medical & Public Health Management (2019 – 2021) from the same institution, graduating with a perfect 10.00 GPA, demonstrating her dedication to academic excellence and healthcare leadership. Her foundational training in midwifery was completed with a Bachelor’s Degree in Midwifery (2014 – 2018) at UMF Carol Davila, Romania, where she distinguished herself as the Class Leader, showcasing her leadership skills and commitment to the profession from the early stages of her career.

💼 Professional Experience

With a strong background in midwifery and maternal healthcare, Radu Mihaela Corina has been actively contributing to both academia and clinical practice. Since 2021, she has been serving as an Associate University Assistant at UMF Carol Davila Bucharest, where she plays a key role in training future midwives and healthcare professionals. In parallel, she holds the position of Head Midwife at Dr. Constantin Andreoiu County Emergency Hospital since 2022, overseeing maternity care and ensuring the highest standards in obstetric practice.

Her passion for maternal education led her to work as a Lecturer in Prenatal Courses at the Rhodos Proviva Family Health Education Center (2020 – 2022), where she provided essential guidance to expectant mothers. Additionally, from 2018 to 2022, she served as the Head Midwife in the Birth Block at Obstetrics and Gynecology Hospital, Ploiesti, where she played a crucial role in labor and delivery management, ensuring safe and effective maternity care. Through these roles, she continues to make a significant impact in both education and clinical midwifery.

🔬 Research Interests

Maternal and Child Health 🏥

Midwifery Education & Practice 👶

Reproductive Health & Ethics 🧬

Medical Policy and Public Health 📊

🏆 Awards & Recognitions

2025: Member of the Ethics Committee, European Midwives Association

2024: National Expert for Romania, EU Project on Midwifery Professional Standards

2022 – Present: AMI Delegate, General Council, International Confederation of Midwives

2020 – Present: Vice President, Association of Independent Midwives, Romania

📚 Selected Publications

(2025) Validation of a Questionnaire Assessing Pregnant Women’s Perspectives on Addressing the Psychological Challenges of Childbirth – Nursing Reports, 15(1):8

(2024) Predictors of Pregnant Women’s Decision to Opt for Cesarean Section in Romania – Cureus, 16(9)

(2024) Exploring Factors Influencing Pregnant Women’s Perceptions and Attitudes Towards Midwifery Care in Romania – Nursing Reports, 14(3), 1807-1818

(2024) COVID-19 and Flu Vaccination in Romania: Post-Pandemic Lessons – PLoS ONE, 19(3)

(2023) Similarities in Midwifery Education, Regulation, and Practice Across Europe – European Journal of Midwifery, 7(Supplement 1)

 

 

 

Dr. Charles Reitman | Medicine and Dentistry | Best Researcher Award

Published on by Invention Awards

Dr. Charles Reitman | Medicine and Dentistry | Best Researcher Award

MUSC Health University Medical Center, United States.

Dr. Charles A. Reitman is a distinguished orthopedic surgeon specializing in spine surgery with decades of experience in medical education, research, and patient care. He has held prestigious academic positions and received numerous awards for his contributions to orthopedic and spinal surgery. Dr. Reitman is widely recognized for his expertise in minimally invasive spine techniques, spinal trauma, and disc arthroplasty.

Profile

Scopus

Orcid

🎓 Education

Charles A. Reitman, MD, pursued his undergraduate studies at the University of California, Davis, earning a BS in Animal Physiology (1974-1978). He then completed a BS and Certificate in Physical Therapy at UCSF, San Francisco (1978-1979), which provided him with foundational expertise in rehabilitation and movement sciences. Dr. Reitman later obtained his MD in Medicine from Baylor College of Medicine (1991-1995), where he developed a strong foundation in clinical practice and surgical techniques. Following medical school, he specialized in orthopedic surgery through a residency at Baylor College of Medicine (1995-2000), refining his skills in musculoskeletal care. To further specialize, he completed a fellowship in Orthopedic Surgery Spine at Baylor College of Medicine (2000-2001), gaining advanced training in complex spinal procedures.

🏥 Experience

Dr. Charles A. Reitman has had a distinguished career in orthopedic surgery, with extensive experience in both academic and clinical settings. Since 2015, he has served as a Professor of Orthopaedics at the Medical College of South Carolina, where he contributes to research, education, and advanced spinal surgery techniques. Prior to this, he was a Professor of Orthopedic Surgery at Baylor College of Medicine (2012-2015), mentoring future surgeons and leading innovative surgical advancements. His tenure at Baylor also included roles as an Associate Professor (2007-2012) and Assistant Professor (2001-2007), during which he played a pivotal role in shaping orthopedic residency programs and conducting groundbreaking research in spine surgery.

🔬 Research Interests

Spinal Surgery & Biomechanics

Minimally Invasive Spine Techniques

Disc Arthroplasty & Spinal Trauma

Spinal Deformity & Degenerative Disorders

Orthopedic Surgery Innovations

🏆 Awards & Honors

UC Davis – Highest Honors (1978)

Alpha Omega Alpha Honor Society (1995)

Baylor College of Medicine – Honors (1995)

Most Outstanding Poster – NASS (1999)

Outstanding Orthopedic Faculty, BCM (2004, 2012, 2013, 2014, 2015)

America’s Top Orthopedists (2007, 2010)

Best Doctors (2007, 2008, 2013)

Texas Super Doctors (2009)

Most Compassionate Doctor Award (2010-2016)

Top 10 Doctor (2014)

Elected into American Orthopedic Association (2011)

MUSC Ortho Faculty of the Year (2019, 2023)

Marquis Who’s Who Lifetime Award (2018)

📚 Selected Publications

Establishing case volume benchmarks for ACGME-accredited orthopedic surgery of the spine fellowship training – Spine J, 2024

Reference Data for Diagnosis of Spondylolisthesis and Disc Space Narrowing Based on NHANES-II X-rays – Bioengineering (Basel), 2024

Regional structure-function relationships of lumbar cartilage endplates – J Biomech, 2024

Diagnosis of spine pseudoarthrosis based on biomechanical properties of bone – Spine J, 2024

ACR Appropriateness Criteria® Stress (Fatigue-Insufficiency) Fracture Including Sacrum – J Am Coll Radiol, 2024

 

 

Xiaochun Li | Biomedical | Best Researcher Award

Published on by Invention Awards

Prof Dr. Xiaochun Li | Biomedical | Best Researcher Award

Associate Dean, Taiyuan University of Technology, China

Dr. Xiaochun Li is a Professor at the Department of Biomedical Engineering, TaiYuan University of Technology, Shanxi, China. With an extensive background in biomedical sensors and analytical chemistry, Dr. Li has made significant contributions to the field through innovative research and teaching. He has received multiple awards for his work, including the Second Prize of the Shanxi Provincial Natural Science Award and recognition as the “2021 Annual Science and Technology Innovation Person.” His research focuses on developing cutting-edge technologies for disease diagnosis and public health.

Profile

Scopus

Education 🎓

Dr. Xiaochun Li earned his Ph.D. in Biomedical Engineering, specializing in analytical chemistry and sensor technology. His educational journey laid a strong foundation for his future research and academic career, leading to his current position as a professor at TaiYuan University of Technology.

Experience 🧑‍🏫

Professor, TaiYuan University of Technology, Shanxi, China (2014-present): Leading research in biomedical sensors and analytical chemistry.

Associate Professor, TaiYuan University of Technology, Shanxi, China (2009-2014): Conducted advanced research and taught various courses.

Assistant Professor, TaiYuan University of Technology, Shanxi, China (2007-2009): Initiated his academic career, focusing on innovative research in biomedical engineering.

Research Interests 🔬

Dr. Xiaochun Li’s research interests encompass the development of biomedical sensors, optical fluorescence detection technologies, and AI-enhanced biochemical sensing. His work is particularly focused on creating innovative diagnostic tools for early disease detection and public health applications.

Awards 🏆

Second Prize of Shanxi Provincial Natural Science Award (2022)

Outstanding Science and Technology Worker of China Society of Electronics (2019)

Silver Prize of National Science and Technology Workers’ Innovation and Entrepreneurship Competition (2016)

Young Outstanding Talents of Shanxi Province “Three Jin Talents” (2018)

2021 Annual Science and Technology Innovation Person (2022)

Publications Top Notes 📚

Zhang, L. L., Xu, P. T., Li, X. C., Yang, Z. H., Yu, H.-Z.. (2024). Blu-ray disc technology-enabled portable imaging system for immunoassay quantitation. Sens. Actuat. B-Chem., 419, 136376. Cited by 15 articles. link

Wang, C. X., Deng, R., Li, H. Q., Liu, Z. G., Niu, X. F., Li, X. C.. (2024). An integrated magnetic separation enzyme-linked colorimetric sensing platform for field detection of Escherichia coli O157: H7 in food. Microchimica Acta, 191, 454. Cited by 10 articles. link

Li, H. Q., Xu, H., Li, Y. L., Li, X. C.*. (2024). Application of artificial intelligence (AI)-enhanced biochemical sensing in molecular diagnosis and imaging analysis: Advancing and challenges. Trac-Trend. Anal. Chem., 174, 117700. Cited by 12 articles. link